Fresh Tracks Therapeutics's total assets for Q4 2023 were $11.59M, a decrease of -11.27% from the previous quarter. FRTX total liabilities were $1.66M for the fiscal quarter, a -21.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.